First, this was a retrospective study and we had no access to patient clinical data (cART regimens, adherence, CD4+ cell counts, HIV viral load, COPD management, active hepatitis C), which could have helped us to more completely interpret our results. This evidence concerns the gene CD4 and hepatitis C virus infection.